Open AccessRandomized placebo control study of metformin in psoriasis patients with metabolic syndrome (systemic treatment cohort)
Author(s) -
Surjit Singh,
Anil Bhansali
Publication year - 2017
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/ijem.ijem_46_17
Subject(s) - medicine , metformin , placebo , body mass index , metabolic syndrome , blood pressure , psoriasis area and severity index , gastroenterology , psoriasis , diabetes mellitus , lipid profile , type 2 diabetes , endocrinology , obesity , insulin , cholesterol , immunology , alternative medicine , pathology
Psoriasis has been found to be associated with obesity, metabolic syndrome (MS), diabetes, and cardiovascular risk factors. Metformin treatment showed improvement in cardiovascular risk factors and hyperinsulinemia.